Meral Beksaç
Active 2000–2026
- Also published as
- Meral Beksac
- 124
- Papers
- 27,248
- Citations
- 69
- h-index
- 111
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine75%
- Biochemistry, Genetics and Molecular Biology17.2%
- Immunology and Microbiology3.4%
- Computer Science2%
- Engineering0.5%
- Social Sciences0.3%
- Other1.6%
Topics
- Multiple Myeloma Research and Treatments21.3%
- Protein Degradation and Inhibitors9.1%
- Peptidase Inhibition and Analysis5.5%
- CAR-T cell therapy research3.1%
- Cancer Treatment and Pharmacology3.1%
- Amyloidosis: Diagnosis, Treatment, Outcomes2.7%
- Other55.2%
Coauthors
- Meletios Α. Dimopoulos64
- Philippe Moreau48
- Michèle Cavo43
- María‐Victoria Mateos35
- Pieter Sonneveld32
- Jesús F. San Miguel30
- Hermann Einsele27
- Roman Hájek26
- Evangelos Terpos25
- Ivan Špıčka25
- Paul G. Richardson24
- Fredrik Schjesvold22
- Heinz Ludwig22
- Xavier Leleu22
- Andrew Spencer21
- Francesca Gay21
- Mario Boccadoro21
- Niels W.C.J. van de Donk21
- Vânia Hungria21
- Hartmut Goldschmidt20
- Michel Delforge20
- Sonja Zweegman20
- Katja Weisel19
- Antonio Palumbo18
All papers
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Authors: S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, Joan Bladé, Giampaolo Merlini, María‐Victoria Mateos, Shaji Kumar, Jens Hillengaß, Efstathios Kastritis, Paul G. Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan M. Weiss, Xavier Leleu, Sonja Zweegman, Sagar Lonial, Laura Rosiñol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurður Y. Kristinsson, Jo Caers, Saad Z. Usmani, Juan José Lahuerta, Hans Erik Johnsen, Meral Beksaç, Michèle Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 cited by 4,869
- Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Authors: Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michèle Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels W.C.J. van de Donk, Eirini Katodritou, Fredrik Schjesvold, Anna Sureda, Laura Rosiñol, Michel Delforge, Wilfried Roeloffzen, Tobias Silzle, Annette Juul Vangsted, Hermann Einsele, Andrew Spencer, Roman Hájek, Artur Jurczyszyn, Sarah Lonergan, Tahamtan Ahmadi, Yanfang Liu, Jianping Wang, Diego Vieyra, Emilie M.J. van Brummelen, Véronique Vanquickelberghe, Anna Sitthi-Amorn, Carla J. de Boer, Robin Carson, Paula Rodríguez‐Otero, Joan Bladé, Philippe Moreau - New England Journal of Medicine 2023 cited by 515
- Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Authors: Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema, Ashutosh Wechalekar, Arnaud Jaccard, Hans C. Lee, Vaishali Sanchorawala, Simon Gibbs, Peter Mollee, Christopher P. Venner, Jin Lu, Stefan Schönland, Moshe E. Gatt, Kenshi Suzuki, Kihyun Kım, M. Teresa Cibeira, Meral Beksaç, Edward N. Libby, Jason Valent, Vânia Hungria, Sandy W. Wong, Michael Rosenzweig, Naresh Bumma, Antoine Huart, Meletios Α. Dimopoulos, Divaya Bhutani, Adam Waxman, Stacey Goodman, Jeffrey A. Zonder, Selay Lam, Kevin Song, Timon Hansen, Salomon Manier, Wilfried Roeloffzen, Krzysztof Jamroziak, Fiona Kwok, Chihiro Shimazaki, Jin Seok Kim, Edvan Crusoé, Tahamtan Ahmadi, NamPhuong Tran, Xiang Qin, Sandra Y. Vasey, Brenda Tromp, Jordan M. Schecter, Brendan M. Weiss, Sen Hong Zhuang, Jessica Vermeulen, Giampaolo Merlini, Raymond L. Comenzo - New England Journal of Medicine 2021 cited by 668
- Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
Authors: Heinz Ludwig, Evangelos Terpos, Niels W.C.J. van de Donk, María‐Victoria Mateos, Philippe Moreau, Melitios-Athanasios Dimopoulos, Michel Delforge, Paula Rodríguez‐Otero, Jesús F. San Miguel, Kwee Yong, Francesca Gay, Hermann Einsele, Roberto Mina, Jo Caers, Christoph Driessen, Pellegrino Musto, Sonja Zweegman, Monika Engelhardt, Gordon Cook, Katja Weisel, Annemiek Broijl, Meral Beksaç, Jelena Bila, Fredrik Schjesvold, Michèle Cavo, Roman Hájek, Cyrille Touzeau, Mario Boccadoro, Pieter Sonneveld - The Lancet Oncology 2023 cited by 178
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Authors: Antonio Palumbo, Asher Chanan‐Khan, Katja Weisel, Ajay K. Nooka, Tamás Masszi, Meral Beksaç, Ivan Špıčka, Vânia Hungria, Markus Munder, María‐Victoria Mateos, Tomer M. Mark, Ming Qi, Jordan M. Schecter, Himal Amin, Xiang Qin, William Deraedt, Tahamtan Ahmadi, Andrew Spencer, Pieter Sonneveld - New England Journal of Medicine 2016 cited by 1,513
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Authors: Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios Α. Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Sandrine Macé, Kathryn P. Corzo, Frank Campana, Solenn Le-Guennec, Franck Dubin, Kenneth C. Anderson, Simon J. Harrison, Wojciech Janowski, Ian Kerridge, Andrew Spencer, Michel Delforge, Karel Fostier, Philip Vlummens, Ka Lung Wu, Richard LeBlanc, Michel Pavic, Michaël Sébag, Roman Hájek, Vladimír Maisnar, Luděk Pour, Henrik Gregersen, Lotfi Benbouker, Denis Caillot, Martine Escoffre‐Barbe, Thierry Façon, Laurent Frenzel, Cyrille Hulin, Lionel Karlin, Brigitte Kolb, Brigitte Pegourié, Aurore Perrot, Mourad Tiab, Laure Vincent, Dietger Niederwieser, Αchilles Anagnostopoulos, Sosana Delimpasi, Marie‐Christine Kyrtsonis, Anargyros Symeonidis, Árpád Illés, Gábor Mikala, Zsolt Nagy, Sara Bringen, Paolo Corradini, Fabio Ciceri, Roberto M. Lemoli, Anna Marina Liberati, Chiara Nozzoli, Renato Zambello, Shinsuke Iida, Takashi Ikeda, Satoshi Iyama, Morio Matsumoto, Chihiro Shimazaki, Kazutaka Sunami, Kenshi Suzuki, Michihiro Uchiyama, Youngil Koh, Kihyun Kım, Jae Hoon Lee, Chang‐Ki Min, Hillary Blacklock, Hugh J. B. Goodman, Annette Neylon, David Simpson, Sebastian Grosicki, Artur Jurczyszyn and 30 more - The Lancet 2019 cited by 636
- International uniform response criteria for multiple myeloma
Authors: Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel, J Bladé, Bart Barlogie, Kenneth C. Anderson, Morie A. Gertz, Meletios Α. Dimopoulos, Jan Westin, Pieter Sonneveld, Heinz Ludwig, Gösta Gahrton, Meral Beksaç, John Crowley, Andrew Belch, M Boccadaro, Ingemar Turesson, D. Joshua, David H. Vesole, Robert A. Kyle, Raymond Alexanian, Guido Tricot, Michel Attal, Giampaolo Merlini, R Powles, Paul G. Richardson, Kazuyuki Shimizu, Patrizia Tosi, Gareth J. Morgan, S. Vincent Rajkumar, on behalf of the International Myeloma Working Group - Leukemia 2006 cited by 2,639
- Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Authors: Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, María‐Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tahamtan Ahmadi, Jon Ukropec, Tobias Kampfenkel, Jordan M. Schecter, Yanping Qiu, Himal Amin, Jessica Vermeulen, Robin Carson, Pieter Sonneveld, Adrián Alegre Amor, Luca Baldini, Meral Beksaç, Angelo Belotti, Lotfi Benboubker, Britta Besemer, Sevgi Kalayoğlu Beşışık, Jelena Bila, Mario Boccadoro, Michèle Cavo, Javier de la Rubia Comos, Sosana Delimpasi, Meletios Α. Dimopoulos, Chantal Doyen, Dominik Dytfeld, Monika Engelhardt, Thierry Façon, Roberto Foà, Hartmut Goldschmidt, Sebastian Grosicki, Roman Hájek, Güner Hayri Özsan, Cyrille Hulin, Brian Iversen, Lionel Karlin, Eirini Katodritou, Stefan Knop, Marie‐Christine Kyrtsonis, Juan José Lahuerta, Xavier Leleu, Carmen Martínez Chamorro, María-Victoria Mateos Manteca, Nathalie Meuleman, Monique C. Minnema, Philippe Moreau, Massino Offidani, Albert Oriol Rocafiguera, Mustafa Pehlıvan, Luděk Pour, Henk Roerdink, Laura Rosinol Dacsh, Hans Salwender, Pieter Sonneveld, Anargyros Symeonidis, Charlotte Toftmann Hansen, Tülin Tuğlular, Ali Ünal, Philip Vlummens, Filiz Vural, Ka Lung Wu, Sonja Zweegman - The Lancet Oncology 2021 cited by 327
- Extramedullary disease in multiple myeloma: a systematic literature review
Authors: Joan Bladé, Meral Beksaç, Jo Caers, Artur Jurczyszyn, Marie von Lilienfeld‐Toal, Philippe Moreau, Leo Rasche, Laura Rosiñol, Saad Z. Usmani, Elena Zamagni, Paul G. Richardson - Blood Cancer Journal 2022 cited by 278
- Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
Authors: Meletios Α. Dimopoulos, Meral Beksac, Luděk Pour, Sosana Delimpasi, Vladimir Vorobyev, Hang Quach, Ivan Spicka, Jakub Radocha, Paweł Robak, Kihyun Kım, Michèle Cavo, Kazuhito Suzuki, Kristin Morris, Farrah Pompilus, Amy Phillips-Jones, Xiaoou L Zhou, Giulia Fulci, Neal Sule, Brandon E. Kremer, Joanna Opalińska, María‐Victoria Mateos, Suzanne Trudel - New England Journal of Medicine 2024 cited by 151
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Authors: Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Ka Lung Wu, Anil Singhal, Jesús F. San Miguel, Morio Matsumoto, Jessica Katz, Eric Bleickardt, Valerie Poulart, Kenneth C. Anderson, Paul G. Richardson - New England Journal of Medicine 2015 cited by 1,320
- Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Authors: Paul G. Richardson, Albert Oriol, Meral Beksaç, Anna Marina Liberati, Mónica Galli, Fredrik Schjesvold, Jindriska Lindsay, Katja Weisel, Darrell White, Thierry Façon, Jesús F. San Miguel, Kazutaka Sunami, Peter O’Gorman, Pieter Sonneveld, Paweł Robak, С. В. Семочкин, Steve Schey, Xin Yu, Thomas Doerr, Amine Bensmaine, Tsvetan Biyukov, Teresa Peluso, Mohamed H. Zaki, Kenneth Anderson, Meletios Α. Dimopoulos, Niels Abildgaard, Howard L. Adler, Fevzi Altuntaş, Olga Meltem Akay, Bipinkumar Amin, Achilleas Anagnostopoulos, Larry D. Anderson, Pekka Anttila, Carla Araujo, Carlos Arce‐Lara, Yıldız Aydın, Supratik Basu, Ramakrishna Battini, Thaddeus Beeker, Lotfi Benboubker, Dina Ben‐Yehuda, Joan Bladé, Igor Wolfgang Blau, Ralph V. Boccia, Lillian Burke, Peter D. Byeff, Nicola Cascavilla, Michèle Cavo, Andrew Chantry, Yen Charles, Arvind Chaudhry, Alessandro Corso, Mark Coyne, Felipe de Arriba, Sosana Delimpasi, Pierre Desjardins, Binod Dhakal, Paolo Di Bartolomeo, Francesco Di Raimondo, Jan Dürig, Monika Engelhardt, Martine Escoffre‐Barbe, Graça Esteves, Max Flogegård, Nashat Gabrail, Barbara Gamberi, Mitchell Garrison, Julie Gay, Heinz Gisslinger, Hartmut Goldschmidt, Cristina Gonçalves, Laurent Gressot, Sebastian Grosicki, Wahid T. Hanna, Patrick Hayden, Maria Manuela Henriques Bernardo, Róbert Hermann, Viran Holden, Kirsti Honkalehto, Marianne Huben, John Huffman, Hannah Hunter, Marek Hus, Madan Jagasia, Sundar Jagganath, Murali Janakiram, Ishmael Jaiyesimi, Matthew Jenner, Cristina João, Peter Johnson, Artur Jurcyszyn, Sevgi Kalayoğlu Beşışık, Suman Kambhampati, Abraham S. Kanate, Ìhsan Karadoǧan, Ali Khojasteh, Dean Kirkel, Mieczysław Komarnicki, Maria‐Theresa Krauth, Phillip Kuriakose and 65 more - The Lancet Oncology 2019 cited by 385
- Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Authors: Thierry Façon, Meletios Α. Dimopoulos, Xavier P Leleu, Meral Beksac, Ludek Pour, Roman Hájek, Zhuogang Liu, Jiri Minarik, Philippe Moreau, Joanna Romejko‐Jarosińska, Ivan Spicka, Vladimir Vorobyev, Britta Besemer, Tadao Ishida, Wojciech Janowski, Sevgi Kalayoğlu Beşışık, Gurdeep Parmar, Paweł Robak, Elena Zamagni, Hartmut Goldschmidt, Thomas Martin, Salomon Manier, Mohamad Mohty, Corina Oprea, Marie-France Brégeault, Sandrine Macé, Christelle Berthou, David Bregman, Zandra Klippel, Robert Z. Orlowski - New England Journal of Medicine 2024 cited by 243
- Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Authors: Philippe Moreau, Shaji Kumar, Jesús F. San Miguel, Faith E. Davies, Elena Zamagni, Nizar J. Bahlis, Heinz Ludwig, Joseph Mıkhael, Evangelos Terpos, Fredrik Schjesvold, Thomas G. Martin, Kwee Yong, Brian G.M. Durie, Thierry Façon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels W.C.J. van de Donk, Sagar Lonial, Michèle Cavo, Sigurður Y. Kristinsson, Suzanne Lentzsch, Roman Hájek, Kenneth C. Anderson, Cristina João, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafaël Fonseca, Annette Juul Vangsted, Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Paul G. Richardson - The Lancet Oncology 2021 cited by 268
- HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA
Authors: Fengjie Jiang, Xiaozhu Tang, Chao Tang, Zhen Hua, Mengying Ke, Chen Wang, Jiamin Zhao, Shengyao Gao, Artur Jurczyszyn, Siegfried Janz, Meral Beksaç, Fenghuang Zhan, Chunyan Gu, Ye Yang - Journal of Hematology & Oncology 2021 cited by 176
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Authors: Paul G Richardson, Aurore Perrot, Jesus San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Jeffrey Shang-Yi Huang, Jiri Minarik, Michele Cavo, H Miles Prince, Laure Malinge, Franck Dubin, Helgi van de Velde, Kenneth C Anderson - The Lancet Oncology 2022 cited by 114
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
Authors: Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon, Meral Beksaç, Meletios Α. Dimopoulos, Ashraf Elghandour, W Wiktor-Jędrzejczak, Andreas Günther, Thanyaphong Na Nakorn, Noppadol Siritanaratkul, Paolo Corradini, Suporn Chuncharunee, Je‐Jung Lee, Robert Schlossman, Tatiana Shelekhova, Kwee Yong, Daryl Tan, Tontanai Numbenjapon, Jamie Cavenagh, Jian Hou, Richard LeBlanc, Hareth Nahi, Lugui Qiu, Hans Salwender, Stefano Pulini, Philippe Moreau, Krzysztof Warzocha, Darrell White, Joan Bladé, Wen‐Ming Chen, Javier de la Rubia, Peter Gimsing, Sagar Lonial, Jonathan L. Kaufman, Enrique M. Ocio, Ljupco Veskovski, Sang Kyun Sohn, Ming-Chung Wang, Jae Hoon Lee, Hermann Einsele, Monika Sopala, Claudia Corrado, B. Bengoudifa, Florence Binlich, Paul G. Richardson - The Lancet Oncology 2014 cited by 788
- Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Authors: Michèle Cavo, Francesca Gay, Meral Beksaç, Lucia Pantani, Maria Teresa Petrucci, Meletios Α. Dimopoulos, Luca Dozza, Bronno van der Holt, Sonja Zweegman, Stefania Oliva, Vincent H. J. van der Velden, Elena Zamagni, Giuseppe A. Palumbo, Francesca Patriarca, Vittorio Montefusco, Mónica Galli, Vladimír Maisnar, Barbara Gamberi, Markus Hansson, Angelo Belotti, Luděk Pour, Paula F. Ypma, Mariella Grasso, Alexsandra Croockewit, Stelvio Ballanti, Massimo Offidani, Iolanda Donatella Vincelli, Renato Zambello, Anna Marina Liberati, Niels Frost Andersen, Annemiek Broijl, Rossella Troia, Anna Pascarella, Giulia Benevolo, Mark‐David Levin, Gerard M.J. Bos, Heinz Ludwig, Sara Aquino, Anna Morelli, Ka Lung Wu, Rinske Boersma, Roman Hájek, Marc Durian, Peter A. von dem Borne, Tommaso Caravita di Toritto, Thilo Zander, Christoph Driessen, Giorgina Specchia, Anders Waage, Peter Gimsing, Ulf‐Henrik Mellqvist, Marinus van Marwijk Kooy, Monique C. Minnema, Caroline M.P.W. Mandigers, Anna Maria Cafro, Angelo Palmas, Susanna Carvalho, Andrew Spencer, Mario Boccadoro, Pieter Sonneveld - The Lancet Haematology 2020 cited by 384
- Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
Authors: Saad Z Usmani, Hang Quach, Maria-Victoria Mateos, Ola Landgren, Xavier Leleu, David Siegel, Katja Weisel, Maria Gavriatopoulou, Albert Oriol, Neil Rabin, Ajay Nooka, Ming Qi, Meral Beksac, Andrzej Jakubowiak, Bifeng Ding, Anita Zahlten-Kumeli, Akeem Yusuf, Meletios Dimopoulos - The Lancet Oncology 2021 cited by 160
- Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial
Authors: Pieter Sonneveld, Asher Chanan‐Khan, Katja Weisel, Ajay K. Nooka, Tamás Masszi, Meral Beksaç, Ivan Špıčka, Vânia Hungria, Markus Munder, María‐Victoria Mateos, Tomer M. Mark, Mark‐David Levin, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Andrew Spencer - Journal of Clinical Oncology 2022 cited by 120
- Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Authors: Laura Rosiñol, Meral Beksaç, Elena Zamagni, Niels W.C.J. van de Donk, Kenneth C. Anderson, Ashraf Badros, Jo Caers, Michèle Cavo, Meletios Α. Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vânia Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A. Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, María‐Victoria Mateos, Giampaolo Merlini, Mohamad Mohty, Philippe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson, Joan Bladé - British Journal of Haematology 2021 cited by 174
- Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
Authors: Meletios Α. Dimopoulos, Giampaolo Merlini, Frank Bridoux, Nelson Leung, Joseph Mıkhael, Simon J. Harrison, Efstathios Kastritis, Laurent Garderet, Alessandro Gozzetti, Niels W.C.J. van de Donk, Katja Weisel, Ashraf Badros, Meral Beksaç, Jens Hillengaß, Mohamad Mohty, P. Joy Ho, Ioannis Ntanasis‐Stathopoulos, María‐Victoria Mateos, Paul G. Richardson, Joan Bladé, Philippe Moreau, Jesús F. San Miguel, Nikhil C. Munshi, S. Vincent Rajkumar, Brian G.M. Durie, Heinz Ludwig, Evangelos Terpos - The Lancet Oncology 2023 cited by 121
- Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Authors: Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis, Evangelos Terpos, Hareth Nahi, Hartmut Goldschmidt, Jens Hillengaß, Xavier Leleu, Meral Beksaç, Melissa Alsina, Albert Oriol, Michèle Cavo, Enrique M. Ocio, María‐Victoria Mateos, Elizabeth O’Donnell, Ravi Vij, H M Lokhorst, Niels W.C.J. van de Donk, Chang‐Ki Min, Tomer M. Mark, Ingemar Turesson, Markus Hansson, Heinz Ludwig, Sundar Jagannath, Michel Delforge, Charalampia Kyriakou, Parameswaran Hari, Ulf‐Henrik Mellqvist, Saad Z. Usmani, Dominik Dytfeld, Ashraf Badros, Philippe Moreau, K Kim, P R Otero, J H Lee, Chaim Shustik, Daniel D. Waller, Wee Joo Chng, Shuji Ozaki, J-J Lee, Javier de la Rubia, Hyeon‐Seok Eom, Laura Rosiñol, Juan José Lahuerta, Anna Sureda, Jin Seok Kim, B G M Durie - Leukemia 2017 cited by 354
- CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
Authors: Chunyan Gu, Wang Wang, Xiaozhu Tang, Tingting Xu, Yanxin Zhang, Mengjie Guo, Rongfang Wei, Yajun Wang, Artur Jurczyszyn, Siegfried Janz, Meral Beksaç, Fenghuang Zhan, Anja Seckinger, Dirk Hose, Jingxuan Pan, Ye Yang - Molecular Cancer 2021 cited by 74
